Encouraging results from a mouse model of shiga toxin-induced TTP have indicated that ADAMTS13 gene transfer has the potential to treat cTTP (Table 1) [74]. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.